Clinical trial
Exogenous Ketone Ester Supplementation in ICU Delirium (KETONES ICU)
NCT07364162 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exogenous Ketone Ester Supplementation in ICU Delirium (KETONES ICU)
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- June 9, 2026
- Completion date
- December 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, icu delirium